Ticker: ADPT

Adaptive Biotechnologies Corporation (NYSE: ADPT) is focused on advancing immune medicine by leveraging the adaptive immune system to enhance disease diagnosis and treatment. The company primarily operates in two segments: Minimal Residual Disease (MRD) and Immune Medicine. The latest quarterly f...